Development course of Guangdong Kaipu Biotechnology Co., Ltd.

With strong independent innovation and R&D advantages, Cape was approved by Guangdong Provincial Science and Technology Department, Provincial Development and Reform Commission and Provincial Economic and Information Committee in 20 12, and established "Guangdong Molecular Diagnosis Engineering Technology Research and Development Center for Human Papillomavirus (HPV)-related diseases", becoming one of the few enterprises with the ability to build a provincial R&D center in the field of molecular diagnosis in China. Cape is also recognized as a high-tech enterprise and innovative enterprise in Guangdong Province.